Simultaneous determination of phenolic acids in Guanxinning injection by HPLC / 中国中药杂志

This paper was aim to determine five phenolic acids, sodium danshensu (SD), protocatechuic aldehyde (PA), rosmarinic acid (RA), lithospermic acid (LA) and salvianolic acid B (SAB), in Guanxinning injection. In the test, Kromasil C18 column (4.6 mm x 250 mm, 5 µm) was adopted, with acetonitrile-3% formic acid solution as the mobile phase for gradient elution. The flow rate was 1 mL · min, the column temperature was 30 °C and the detection wavelength was 280 nm. According to the results of the test, SD, PA, RA, LA and SAB showed good linear relations between peak areas and sample sizes in 0.006 06-4.04 (r = 0.999 3), 0.006 15-4.10 (r = 0.999 4), 0.005 94-3.96 (r = 0.999 3), 0.006 06-4.04(r = 0.999 1) and 0.006 09-4.06 (r = 0.999 2) µg, respectively. The average recoveries (n = 6) were 98.9% (RSD 0.75%), 98.1% (RSD 1.2%), 100% (RSD 0.77%), 98.7% (RSD 1.7%), 102% (RSD 0.68%), respectively. The above 5 components were determined in 13 batches of samples by using the established method. The method was simple, accurate and highly reproducible that it could be used for quality control of the components in Guanxinning injection.

Discussion on problems of management and recognition of none packaging medicines in hospital / 中国药学杂志

OBJECTIVE: To explore the problems of the management and identification of the none packaging medicines (This article refers to the bare tablets, capsules and pills.) in the hospital. METHODS: The problems of the management and identification of the none packaging medicines were analyzed and summarized by investigating some hospitals that use the automatic-pack machine to package medicines. RESULTS: Some security risks exist during the management of none packaging drugs in hospitals. The none packaging medicines can not be effectively checked because of lack of standard control when the nurses administered them. CONCLUSION: Measures proposed in this paper can provide ideas and methods for solving these problems and help promote medication safety.

Discussion about risk and management of Chinese patent medicine with double identity / 中国中药杂志

Chinese patent medicine with double identity was a special phenomenon, and many preparations not only were prescription drugs but also over the counter ( OTC) drugs, which brought a lot of trouble. Based on statistics of list of OTC medicines of CFDA, related varieties, route of administration and functions of these drugs were searched. The causes of insufficient were analyzed and the potential risk was investigated. To ensure the safety of drug usage for the patient, risk management system should be set up by improving the technical requirements for registration, improving the drug labels and manuals, playing the role of pharmacists in pharmacy services and raising awareness of doctor and patient for these drugs.